# A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations

> clinical trial · VERIFIED · 2026-07-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: R-Pharm · Condition: Multiple Sclerosis

- Company: R-Pharm
- Sector: Multiple Sclerosis
- Primary source: https://clinicaltrials.gov/study/NCT07597668

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.